However, according to clinicaltrials.gov portal, almost no studies are reported for OX40 (TNFRSF4) related molecules in pancreas cancers, prostate cancers, pheochromocytoma cancers, testis cancer, thymoma, glioma, thyroid cancers nor in adrenocortical cancers. Here, TNFRSF4 is linked to prostate cancer.